Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer

Benedito A. Carneiro, Ramesh K. Ramanathan, Marwan G. Fakih, Smitha S. Krishnamurthi, Barry C. Lembersky, Ronald G. Stoller, Stewart L. Lancaster, Richard A. Pinkerton, Theodore L. Crandall, Amy R. Schmotzer, Douglas M. Potter, Nathan Bahary

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences